| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89943426df0bb84e4c555eefc52ab02c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00005 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1485 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F5-08 |
| filingDate |
2015-03-31^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314e111eb5ac1d1971dff96dcd523bb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bc84e00e1fbb08b2136f63ed9ac943e |
| publicationDate |
2021-09-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3881808-A1 |
| titleOfInvention |
Post nasal drip treatment |
| abstract |
Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient. |
| priorityDate |
2014-04-03^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |